Phio Pharmaceuticals PHIO
NASDAQ PHIO
$1.03 +0.00 (+0.00%)
At close: Sep 30, 2026 · 4:00 PM EDT

Phio Pharmaceuticals (PHIO) Interest Expenses (2024 - 2025)

Updated

Phio Pharmaceuticals (PHIO) reported Interest Expenses of -$125,000 for Q1 2025, compared with -$53,000 a year earlier.

Analysis

Phio Pharmaceuticals (PHIO) Interest Expenses (2024 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 281.00 Mn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn -
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn -
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn -462.00 Mn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -435.00 Mn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 673.00 Mn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 247.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn -
10 Phio Pharmaceuticals 11.97 Mn 11.97 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 -125,000.00
Mar 31, 2024 -53,000.00
API Access

Phio Pharmaceuticals Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-expenses&ticker=PHIO&period=max&api_key=YOUR_API_KEY